glp-1 alzheimer's 2025 Disappointing Results in Trial: Underscores Promise (and Limits) of Single-Agent Approaches GLP-1 Agonists and Dementia -
Description
Effects of rehabilitation management on gastric emptying function in older adults with diabetes
Samtidig er mobiloptimering afgrende
In clinical trials, once-weekly semaglutide at diabetes doses (0.51 mg) produces mean weight loss of 46 kg (913 lbs), while the 2.4 mg dose (Wegovy) achieves average weight reductions of 1215% of body weight
Some emerging studies suggest that tapering off GLP-1s can help blunt this effect
Why are these patients most at risk after starting GLP-1s
10.3803/EnM.2021.1155 79 JourdanJ
